25 January 2024 in Science Editing
Artificial intelligence (AI)-powered chatbots are rapidly supplanting human-derived scholarly work in the fast-paced digital age. This necessitates a re-evaluation of our traditional research and publication ethics, which is the focus of this article. We explore the ethical issues that arise when AI chatbots are employed in research and publication. We critically examine the attribution of academic work, strategies for preventing plagiarism, the trustworthiness of AI-generated content, and the integration of empathy into these systems. Current approaches to ethical education, in our opinion, fall short of appropriately addressing these problems. We propose comprehensive initiatives to tackle these emerging ethical concerns. This review also examines the limitations of current chatbot detectors, underscoring the necessity for more sophisticated technology to safeguard academic integrity. The incorporation of AI and chatbots into the research environment is set to transform the way we approach scholarly inquiries. However, our study emphasizes the importance of employing these tools ethically within research and academia. As we move forward, it is of the utmost importance to concentrate on creating robust, flexible strategies and establishing comprehensive regulations that effectively align these potential technological developments with stringent ethical standards. We believe that this is an essential measure to ensure that the advancement of AI chatbots significantly augments the value of scholarly research activities, including publications, rather than introducing potential ethical quandaries.
1 January 2015 in Journal of Korean Medical Science
Jo HS, et al. J Korean Med Sci. 2015 Oct;30(Suppl 1):S81-S87. https://doi.org/10.3346/jkms.2015.30.S1.S81
1 January 2021 in Journal of Korean Medical Science
Cho KH, et al. J Korean Med Sci. 2021 Nov;36(47):e320. https://doi.org/10.3346/jkms.2021.36.e320
16 October 2024 in Clinical and Experimental Emergency Medicine
Objective This study assessed the efficacy of electrocardiogram (ECG) compared to pulse oximetry (PO) in detecting heart rate (HR) during high-risk newborn resuscitation. Methods A prospective observational study was performed with high-risk delivery cases to measure the time required for HR detection. A conventional PO and a standard ECG monitor were used for HR assessment. Results Forty-one infants were analyzed in the study, and 11 needed resuscitation. The study population was divided according to gestational age (GA): 9 were GA <32 weeks, 28 were GA 32–35 weeks, and 4 were GA ≥36 weeks. Time from ECG placement to HR detection (median, 30 seconds; interquartile range [IQR], 20–43.5 seconds) was significantly faster than that from PO placement (median, 125 seconds; IQR, 100–175 seconds; P<0.001). Time from ECG placement to HR detection was shortest in infants with GA <32 weeks at birth (19 seconds [IQR, 11.5–30.0] for GA <32 weeks vs. 34.5 seconds [IQR, 25.0–44.3] for GA 32–35 weeks vs. 39.5 seconds [IQR, 30.0–64.8] for GA ≥36 weeks; P=0.039). Conclusion ECG effectively evaluated HR during neonatal resuscitation compared to PO. Low- GA infants who require resuscitation may benefit from HR evaluation with nearby standard ECG.
31 May 2026 in Neonatal Medicine
The pathophysiology of patent ductus arteriosus (PDA) is conventionally attributed to increased pulmonary blood flow and reduced systemic organ perfusion caused by left-to-right ductal shunting. Although PDA has been associated with major complications of prematurity and neurodevelopmental impairment, establishing direct causality remains challenging due to multiple confounders, including interactions among risk factors inherent to prematurity, variability in PDA severity and exposure duration, and the effects of interventions themselves. Accumulating evidence supports interpreting PDA in preterm infants as a biomarker of physiological vulnerability and comorbidity severity rather than as a primary causative condition. Prophylactic or early routine pharmacological closure has not demonstrated consistent benefits over conservative management with expectant closure in terms of mortality, short-term morbidity, or long-term neurodevelopmental outcomes. Prospective studies have confirmed that conservative management is a viable treatment strategy even in extremely preterm infants born before 28 weeks of gestation. Major international guidelines recommend that closure be considered only when echocardiographic evidence of hemodynamic compromise is accompanied by clinical symptoms, with pharmacological therapy as the first-line treatment. When pharmacological treatment fails or is contraindicated, the choice and timing of transcatheter ductal occlusion or surgical ligation should be determined based on the patient’s cardiorespiratory status, comorbidities, institutional availability, and anticipated risks. PDA management should be guided by the clinical judgment of experienced neonatologists with comprehensive knowledge of each patient rather than by adherence to uniform protocols. In the domestic neonatal care setting, individualized management strategies developed through multidisciplinary collaboration should be given appropriate consideration.